KPV and airway epithelium: NF-κB and inflammatory markers in cell culture

Level of evidence: Cell study

Research question

Does KPV affect inflammatory signals in bronchial epithelial cells? This study examines a different tissue model than the previously described intestinal studies.

Study model

Inflammatory responses were induced in an immortalized human bronchial cell line. The researchers measured, among other things, NF-κB signaling, MMP-9 activity, and the secretion of IL-8 and eotaxin.

What was found?

In this model, KPV reduced the measured NF-κB activity, MMP-9 activity, and certain inflammatory signals. Another melanocortin compound was also investigated.

Limitations and interpretation

Human cells in a laboratory are not a clinical trial in humans. The findings do not prove efficacy for asthma or other respiratory diseases. Effects of the other compound investigated must not automatically be attributed to KPV.

Original publication

Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. PMID: 22837805. View the original publication on PubMed.

This summary is based on the available source description and abstract; it is not a complete systematic review.

All Peptidera products are intended solely for scientific research and laboratory use. Not for human or animal consumption, self-administration, diagnosis, or treatment.